These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 24622348

  • 1. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
    Fissolo N.
    Mult Scler; 2014 Oct; 20(11):1545. PubMed ID: 24622348
    [No Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
    Pender MP, Csurhes PA, Smith C, Beagley L, Hooper KD, Raj M, Coulthard A, Burrows SR, Khanna R.
    Mult Scler; 2014 Oct; 20(11):1541-4. PubMed ID: 24493474
    [Abstract] [Full Text] [Related]

  • 3. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.
    Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
    [Abstract] [Full Text] [Related]

  • 4. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.
    Lucas KG, Sun Q.
    Pediatr Transplant; 2006 Mar; 10(2):142-4. PubMed ID: 16573596
    [Abstract] [Full Text] [Related]

  • 6. Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.
    Heslop HE, Sharma S, Rooney CM.
    J Clin Oncol; 2021 Feb 10; 39(5):514-524. PubMed ID: 33434061
    [No Abstract] [Full Text] [Related]

  • 7. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.
    O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L.
    Springer Semin Immunopathol; 1998 Feb 10; 20(3-4):455-91. PubMed ID: 9870257
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
    Burns DM, Crawford DH.
    Blood Rev; 2004 Sep 10; 18(3):193-209. PubMed ID: 15183903
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?
    Pender MP, Khanna R.
    Immunotherapy; 2014 Sep 10; 6(6):659-61. PubMed ID: 25186599
    [No Abstract] [Full Text] [Related]

  • 10. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
    Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A.
    J Immunol; 2010 May 15; 184(10):5895-902. PubMed ID: 20385879
    [Abstract] [Full Text] [Related]

  • 11. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.
    Mautner J, Bornkamm GW.
    Eur J Cell Biol; 2012 Jan 15; 91(1):31-5. PubMed ID: 21458882
    [Abstract] [Full Text] [Related]

  • 12. When magic bullets miss their mark.
    Levitsky HI.
    Blood; 2001 Feb 15; 97(4):833. PubMed ID: 11159502
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.
    Eom HS, Choi BK, Lee Y, Lee H, Yun T, Kim YH, Lee JJ, Kwon BS.
    J Immunother; 2016 Apr 15; 39(3):140-8. PubMed ID: 26938947
    [Abstract] [Full Text] [Related]

  • 17. [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection].
    Babel N, Hammer MH, Reinke P.
    Dtsch Med Wochenschr; 2003 Mar 14; 128(11):548-50. PubMed ID: 12635027
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
    Lugthart G, Albon SJ, Ricciardelli I, Kester MG, Meij P, Lankester AC, Amrolia PJ.
    J Immunother; 2012 Jan 14; 35(1):42-53. PubMed ID: 22130159
    [Abstract] [Full Text] [Related]

  • 19. Antigen-specific T cells for the treatment of infections after transplantation.
    Einsele H.
    Hematol J; 2003 Jan 14; 4(1):10-7. PubMed ID: 12692515
    [Abstract] [Full Text] [Related]

  • 20. [Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases].
    Kuzushima K.
    Rinsho Ketsueki; 2000 Jun 14; 41(6):487-90. PubMed ID: 10921347
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.